Article
PP1, PKA and DARPP‐32 in breast cancer: A retrospective assessment of protein and mRNA expression
15 May 2021
Abstract excerpt
Cyclic AMP-dependent protein kinase A (PKA) and protein phosphatase 1 (PP1) are proteins involved in numerous essential signalling pathways that modulate physiological and pathological functions. Both PP1 and PKA can be inhibited by dopamine- and cAMP-regulated phosphoprotein 32 kD (DARPP-32). Using immunohistochemistry, PKA and PP1 expression was determined in a large primary breast tumour cohort to evaluate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
